Financiamento e IncentivoàPesquisa from Hospital de Clínicas de Porto Alegre(FIPE/HCPA),No.2020-0037;Coordination for the Improvement of Higher Education Personnel,CAPES/PNPD;and the Conselho Nacional de Desenvolvimento Científico e Tecnológico(CNPq).
BACKGROUND Metabolic-dysfunction associated steatotic liver disease(MASLD)is a hepatic manifestation of metabolic syndrome.Studies suggest ornithine aspartate(LOLA)as drug therapy.AIM To analyze the influence of LOLA ...
supported by the Michael J.Fox Foundation for Parkinson’s Research(MJFF)grant 16879(M.X.H)and Aligning Science Across Parkinson’s ASAP-020616 through MJFF;NIH grants:R01-AG077573(D.S.B,M.X.H.);NSF grants PHY-1554488(D.S.B)and BCS-1631550(D.S.B).D.S.B.also acknowledges support from the John D.and Catherine T.MacArthur Foundation,the ISI Foundation,the Alfred P.Sloan Foundation,and the Paul G.Allen Foundation.
Background Mutations in leucine-rich repeat kinase 2(LRRK2)are the most common cause of familial Parkinson’s disease(PD).These mutations elevate the LRRK2 kinase activity,making LRRK2 kinase inhibitors an attractive ...
Proper regulation of Wnt signaling is critical for normal bone development and homeostasis.Mutations in several Wnt signaling components,which increase the activity of the pathway in the skeleton,cause high bone mass ...